Amiloidózis: vizsgálatok itt: Kína
38 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleStudy Evaluating the Efficacy and Safety of CM336 Injection in the Treatment of Light-Chain Amyloidosis
- Where
- Beijing, Tianjin
- Életkor
- 18 év and over
- People
- 90
- Run by
- Keymed Biosciences Co.Ltd
See details and how to joinNCT07039578 - 4. fázisTaking peopleA Prospective Cohort Study on Primary Cutaneous Amyloidosis
- Where
- Chongqing
- Életkor
- 18 év and over
- People
- 56
- Run by
- Army Medical University, China
See details and how to joinNCT06998875 - 4. fázisTaking peopleTo Evaluate the Efficacy and Safety of Tafamidis Meglumine Soft Capsules in the Treatment of Adult Patients With Transthyretin Amyloid Polyneuropathy
- Where
- Jinan
- Életkor
- 18 év to 80 év
- People
- 15
- Run by
- Qilu Pharmaceutical Co., Ltd.
See details and how to joinNCT06940336 - Korai 1. fázisTaking peopleSafety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms Clinical Research
- Where
- Hefei
- Életkor
- 19 év to 75 év
- People
- 36
- Run by
- Anhui Provincial Hospital
See details and how to joinNCT07085559 - 2. fázisTaking peopleTeclistamab in Newly Diagnosed Mayo Stage IIIB AL Amyloidosis
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 35
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT07079423 - 2. fázisTaking peopleTeclistamab in Previously Treated AL Amyloidosis
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 30
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT06935162 - No phaseTaking peopleProspective Study of Teclistamab in the Treatment of Systemic AL Amyloidosis
- Where
- Beijing
- People
- 20
- Run by
- Peking University People's Hospital
See details and how to joinNCT06699394 - Korai 1. fázisTaking peopleEfficacy and Safety of Intravenous YOLT-201 for Transthyretin Amyloidosis Cardiomyopathy
- Where
- Hangzhou
- Életkor
- 18 év to 80 év
- People
- 7
- Run by
- Zhejiang University
See details and how to joinNCT06082050 - 2. fázisTaking peopleBortezomib, Pomalidomide, Dexamethasone for Systemic AL Amyloidosis
- Where
- Beijing
- Életkor
- 18 év to 90 év
- People
- 40
- Run by
- Jin Lu, MD
See details and how to joinNCT06342466 - No phaseTaking peopleDaratumumab for Patients With Light Chain Amyloidosis
- Where
- Nanjing
- Életkor
- 18 év to 75 év
- People
- 100
- Run by
- Nanjing University School of Medicine
See details and how to joinNCT06376214 - No phaseCsak meghívásosAutologous Stem Cell Transplantation for Patients With AL Amyloidosis
- Where
- Nanjing
- Életkor
- 18 év to 75 év
- People
- 500
- Run by
- Nanjing University School of Medicine
See details and how to joinNCT04210791 - No phaseTaking peopleClinical Study for AL-CM
- Where
- Hangzhou
- Életkor
- 18 év to 80 év
- People
- 400
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT04924998 - 4. fázisTaking peopleClinical Study of ATTR-CM
- Where
- Hangzhou
- Életkor
- 18 év to 80 év
- People
- 100
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT04935021